Seoul National University Hospital is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Its headquarters are in Yongon-dong, Jongno-gu in Seoul.

There are 1,625 (Main Branch) beds in Seoul National University Hospital.

During the past decade, Seoul National University Hospital conducted 1696 clinical trials. In the 10-year time frame, 1696 clinical trials started and 361 clinical trials were completed, i.e. on average, 21.3% percent of trials that started reached the finish line to date. In the past 5 years, 791 clinical trials started and 254 clinical trials were completed. i.e. 32.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seoul National University Hospital" #1 sponsor was "Seoul National University Hospital" with 985 trials, followed by "Hoffmann-La Roche" with 114 trials sponsored, "Pfizer" with 68 trials sponsored, "Janssen Research & Development, LLC" with 42 trials sponsored and "Boehringer Ingelheim" with 42 trials sponsored. Other sponsors include 1163 different institutions and companies that sponsored additional 414 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul National University Hospital" #1 collaborator was "Seoul National University Hospital" with 63 trials as a collaborator, "Seoul National University Bundang Hospital" with 50 trials as a collaborator, "Samsung Medical Center" with 40 trials as a collaborator, "Asan Medical Center" with 35 trials as a collaborator and "Severance Hospital" with 26 trials as a collaborator. Other collaborators include 1178 different institutions and companies that were collaborators in the rest 519 trials.

According to Clinical.Site data, the most researched conditions in "Seoul National University Hospital" are "Healthy" (66 trials), "Breast Cancer" (50 trials), "Hepatocellular Carcinoma" (44 trials), "Coronary Artery Disease" (39 trials) and "Gastric Cancer" (37 trials). Many other conditions were trialed in "Seoul National University Hospital" in a lesser frequency.

Most popular intervention types in "Seoul National University Hospital" are "Drug" (1539 trials), "Procedure" (242 trials), "Other" (214 trials), "Device" (211 trials) and "Biological" (157 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (302 trials), "Atezolizumab" (56 trials), "Paclitaxel" (46 trials), "Carboplatin" (45 trials) and "Cisplatin" (39 trials). Other intervention names were less common.

The vast majority of trials in "Seoul National University Hospital" are 2125 trials for "All" genders, 144 trials for "Female" genders and 141 trials for "Male" genders.

Currently, there are 759 active trials in "Seoul National University Hospital". 20 are not yet recruiting, 448 are recruiting, 282 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 1153 completed trials in Seoul National University Hospital, 1 suspended trials, and 130 terminated clinical trials to date.

Out of the total trials that were conducted in Seoul National University Hospital, 410 "Phase 1" clinical trials were conducted, 493 "Phase 2" clinical trials and 588 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 188 trials, and there were also 533 trials that are defined as “Not Applicable".

Seoul National University Hospital has several departments that took part in Clinical trials: "Seoul National University Children's Hospital" - 26 trials, "Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine" - 11 trials, "Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine" - 7 trials, "Department of Neurology Seoul National University Hospital" - 6 trials, "Seoul National University Hospital, Department of Internal Medicine" - 41 trials, "Seoul National University Hospital , Cardiovascular Center" - 5 trials, "Department of Anesthesiology and Pain Medicine, Seoul National University Hospital" - 5 trials, "Seoul National University Hospital, Rheumatology, Internal Medicine" - 5 trials, "Seoul National University Hospital (SNUH) - Medical Oncology Center" - 5 trials, "Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine" - 5 trials, "Seoul National University Hosp; Dept Internal Med Hem Onc" - 4 trials, "Department of Ophthalmology, Seoul National University Hospital" - 4 trials, "Department of Urology, Seoul National University Hospital" - 3 trials, "Seoul National University Hospital, Dept. of Clinical Pharmacology" - 3 trials, "Clinical Trials Center Pharmacy" - 2 trials, "Department of Anesthesiology and Pain Medicine" - 30 trials, "Department of Surgery, Seoul National University Hospital" - 6 trials, "CTC Pharmacy, Seoul National University Hospital" - 2 trials, "Clinical Trial Pharmacy" - 2 trials, "Department of Dermatology, Seoul National University Boramae Hospital" - 2 trials, "Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine" - 2 trials